The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints

The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints

Hepatocellular carcinoma (HCC) is a challenging malignancy characterised by clinical and biological heterogeneity, independent of the stage. Despite the application of surveillance programs, a substantial proportion of patients are diagnosed at advanced stages when curative treatments are no longer...

Full description

Bibliographic Details
Main Authors: Paolo Giuffrida, Ciro Celsa, Michela Antonucci, Marta Peri, Maria Vittoria Grassini, Gabriele Rancatore, Carmelo Marco Giacchetto, Roberto Cannella, Lorena Incorvaia, Lidia Rita Corsini, Piera Morana, Claudia La Mantia, Giuseppe Badalamenti, Giuseppe Brancatelli, Calogero Cammà, Giuseppe Cabibbo
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biomedicines
Subjects:
hepatocellular carcinoma
HCC
systemic therapy
immunotherapy
endpoints
radiological criteria
Online Access:https://www.mdpi.com/2227-9059/10/11/2827

Internet

https://www.mdpi.com/2227-9059/10/11/2827

Similar Items